These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 709267)

  • 1. Package inserts for prescribed medicines: what minimum information do patients need?
    Hermann F; Herxheimer A; Lionel ND
    Br Med J; 1978 Oct; 2(6145):1132-5. PubMed ID: 709267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug package inserts and the adequacy of patient's drug information].
    da Silva T; Dal-Pizzol F; Bello CM; Mengue SS; Schenkel EP
    Rev Saude Publica; 2000 Apr; 34(2):184-9. PubMed ID: 10881155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?
    Hamrosi KK; Raynor DK; Aslani P
    Res Social Adm Pharm; 2014; 10(4):656-68. PubMed ID: 24239213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug package inserts--varying information for the same medicines].
    Storflor JG; Pettersen LC; Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2013 May; 133(9):955-9. PubMed ID: 23652143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of German package inserts.
    Fuchs J; Hippius M; Schaefer M
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):8-13. PubMed ID: 16425965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of outpatients' use and needs of patient medicine information leaflets in Thailand.
    Pongpunna S; Pratipanawatr T; Jarernsiripornkul N
    Int J Clin Pharm; 2019 Feb; 41(1):141-150. PubMed ID: 30446897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problems identified in the package leaflets of the Portuguese non-generic medicines].
    Pires C; Cavaco A; Vigário M
    Acta Med Port; 2015; 28(1):21-8. PubMed ID: 25817494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What information for the patient? Large scale pilot study on experimental package inserts giving information on prescribed and over the counter drugs.
    Servizio di Informazione e di Educazione Sanitaria
    BMJ; 1990 Dec; 301(6763):1261-5. PubMed ID: 2271829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug package inserts in India.
    Lal A; Sethi A
    Ann Pharmacother; 1996 Sep; 30(9):1041. PubMed ID: 8876877
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical information in drug package inserts in India.
    Shivkar YM
    J Postgrad Med; 2009; 55(2):104-7. PubMed ID: 19550054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Readability Analysis of the Package Leaflets for Biological Medicines Available on the Internet Between 2007 and 2013: An Analytical Longitudinal Study.
    Piñero-López MÁ; Modamio P; Lastra CF; Mariño EL
    J Med Internet Res; 2016 May; 18(5):e100. PubMed ID: 27226241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishing a System for Effectively Explaining Indications for Driving Prohibition Contained in Drug Package Inserts].
    Tanaka M
    Yakugaku Zasshi; 2017; 137(3):337-340. PubMed ID: 28250330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Readability formulas: are they enough?
    Hoar N; Hoar ME
    Contemp Pharm Pract; 1981; 4(3):145-9. PubMed ID: 10252151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate use of oral drops: perception of health professionals and assessment of package insert information.
    Zaid AN; Al-Ramahi R; Abu Ghoush A
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):854-9. PubMed ID: 21084041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do Australian consumers, pharmacists and prescribers think about documenting indications on prescriptions and dispensed medicines labels?: A qualitative study.
    Garada M; McLachlan AJ; Schiff GD; Lehnbom EC
    BMC Health Serv Res; 2017 Nov; 17(1):734. PubMed ID: 29141618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'What do patients want?' Tailoring medicines information to meet patients' needs.
    Young A; Tordoff J; Smith A
    Res Social Adm Pharm; 2017 Nov; 13(6):1186-1190. PubMed ID: 27818214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Package leaflets of the most consumed medicines in Portugal: safety and regulatory compliance issues. A descriptive study.
    Pires C; Vigário M; Cavaco A
    Sao Paulo Med J; 2015; 133(2):91-100. PubMed ID: 25337666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive medical information increase in package inserts.
    Fuchs J; Werner S; Scheunpflug C; Götze EA; Elstermann K; Scheffel K; Domnowski A; Peter G; Hertzsch C; Hippius M
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):781-90. PubMed ID: 21084033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. User testing as a method for identifying how consumers say they would act on information related to over-the-counter medicines.
    Tong V; Raynor DK; Aslani P
    Res Social Adm Pharm; 2017; 13(3):476-484. PubMed ID: 27423784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.